Quarterly report [Sections 13 or 15(d)]

STOCK OPTIONS

STOCK OPTIONS

6 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

NOTE 11- STOCK OPTIONS

A summary of the status of the Company’s outstanding stock options and changes during the periods is presented below:

	Shares available to purchase			Weighted Average		Weighted Average Remaining Contractual		Aggregate
	with options			Exercise Price		Term (in years)		Intrinsic Value
Outstanding, December 31, 2024		3,640,000		$	0.17		9.02	$	-
Issued		-			-		-
Exercised		-			-		-		-
Cancelled		(37,500	)		0.17		-		-
Expired		-			-		-		-
Outstanding, June 30, 2025		3,602,500		$	0.17		8.53	$	-

Exercisable, June 30, 2025		1,818,529		$	0.17		8.31	$	-

Outstanding, December 31, 2023		-		$	-		-	$	-
Issued		5,050,000			0.17		8.99		-
Exercised		-			-		-		-
Cancelled		(290,000	)		0.17		-		-
Expired		-			-		-		-
Outstanding, June 30, 2024		4,760,000		$	0.17		9.51	$	-

Exercisable, June 30, 2024		733,330		$	0.17		9.51	$	-

The compensation expense attributed to the issuance of the stock options is recognized as they vest.

Total compensation expense related to the stock options was $40,750 and $122,807 for the three and six months ended June 30, 2025, respectively; total compensation expense related to the stock options was $22,403 and $115,122 for the three and six months ended June 30, 2024, respectively, and was included in compensation expense on the statement of operations. As of June 30, 2025, there was $271,815 in future compensation cost related to non-vested stock warrants.

The aggregate intrinsic value as of June 30, 2025 is zero for total outstanding and exercisable options, which was based on our estimated fair value of the Class A common stock of $0.03, had all option holders exercised their options as of that date, net of the aggregate exercise price.